Sinocare

Sinocare Inventory

The Inventory of Sinocare (300298.SZ) as of Oct 24, 2026 is 760.18 M CNY. In the previous year, Inventory was 662.84 M CNY — a change of 14.69% (higher).

Inventory

760.18 MCNY

YoY

14.69%

Last updated:

Inventory of Sinocare is 2025 760.18 M CNY. Inventory of Sinocare was 2024 662.84 M CNY. It decreases by 14.69% higher compared to the previous year.

The Sinocare Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
227.45 M CNY
Jan 1, 2019
249.75 M CNY
Jan 1, 2020
312.82 M CNY
Jan 1, 2021
330.80 M CNY
Jan 1, 2022
416.79 M CNY
Jan 1, 2023
632.45 M CNY
Jan 1, 2024
662.84 M CNY
Jan 1, 2025
760.18 M CNY
The Sinocare Inventory history
YEARInventoryYoY
760.18 MCNY+14.69%
662.84 MCNY+4.81%
632.45 MCNY+51.74%
416.79 MCNY+26.00%
330.80 MCNY+5.75%
312.82 MCNY+25.25%
249.75 MCNY+9.80%
227.45 MCNY+253.69%
64.31 MCNY+28.29%
50.13 MCNY-6.49%
53.61 MCNY+31.78%
40.68 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sinocare Stock analysis

What does Sinocare do? Sinocare, Inc. generates revenue through the development, production, and sale of chronic disease rapid detection products, primarily focusing on blood sugar monitoring systems. The company offers blood sugar testing instruments, related strips, blood sugar testing systems, and mobile blood sugar instruments under its SANNUO brand. These products are sold domestically and internationally, targeting healthcare providers and consumers managing diabetes. Sinocare also provides diabetes management information systems as part of its product portfolio. The SANNUO brand is central to Sinocare's sales strategy, with products distributed across domestic and overseas markets. The company's offerings include micro blood instant blood sugar monitoring systems, which are designed for chronic disease management. Sinocare's revenue streams are derived from direct sales of these medical devices and associated information systems to end-users and healthcare institutions. Sinocare's business model relies on the consistent demand for diabetes management solutions, with its SANNUO-branded products serving both individual consumers and healthcare facilities. The company's product range includes blood sugar testing instruments, strips, and mobile blood sugar instruments, all marketed under the SANNUO label. These products are distributed globally, supporting Sinocare's revenue generation through direct sales channels. Sinocare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sinocare stock

Inventory of Sinocare is 760.18 M CNY in 2025.

Inventory of Sinocare changed from 662.84 M CNY to 760.18 M CNY, representing a 14.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Sinocare since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Sinocare historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sinocare

All Key Metrics — Sinocare